Claret Medical Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
120
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$270M
Claret Medical General Information
Description
Developer of a cerebral protection system designed to reduce the risk of stroke during transcatheter aortic valve replacement (TAVR). The company's cerebral protection system offers endovascular technology and cerebral vascular-protection systems for transcatheter aortic valve implantation and surgical aortic valve replacement, enabling medical institutes to capture and remove debris dislodged during TAVR procedures, preventing it from traveling to the brain where it may cause injury.
Contact Information
Website
www.claretmedical.comCorporate Office
- 1745 Copperhill Parkway
- Suite 1
- Santa Rosa, CA 95403
- United States
Corporate Office
- 1745 Copperhill Parkway
- Suite 1
- Santa Rosa, CA 95403
- United States
Claret Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 02-Aug-2018 | $270M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series C) | 01-Oct-2017 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B2) | 03-Jun-2016 | Completed | Generating Revenue | |||
| 4. Debt - General | 03-Mar-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 01-Apr-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 24-Aug-2011 | $4.33M | $4.33M | Completed | Startup | |
| 1. Early Stage VC | 01-Jan-2009 | Completed | Startup |
Claret Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B-2 | ||||||||
| Series B-1 | 20,271,214 | $0.000010 | 8% | $0.39 | $0.39 | 1x | $0.33 | 13.46% |
| Series A | 4,779,181 | $0.000010 | 8% | $1 | $1 | 1x | $0.33 | 8.24% |
Claret Medical Comparisons
Industry
Financing
Details
Claret Medical Competitors (16)
One of Claret Medical’s 16 competitors is Open Stent Solution, a Venture Capital-Backed company based in Amiens, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Open Stent Solution | Venture Capital-Backed | Amiens, France | ||||
| Emboline | Venture Capital-Backed | Santa Cruz, CA | ||||
| Revamp Medical | Venture Capital-Backed | Netania, Israel | ||||
| Emblok | Private Equity-Backed | Tampa, FL | ||||
| Artio | Venture Capital-Backed | Prairie Village, KS |
Claret Medical Patents
Claret Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11382441-B2 | Portable filter | Active | 26-Apr-2019 | ||
| US-20200337486-A1 | Portable filter | Active | 26-Apr-2019 | ||
| US-11351023-B2 | Systems and methods for protecting the cerebral vasculature | Active | 21-Aug-2018 | ||
| US-11439491-B2 | Systems and methods for protecting the cerebral vasculature | Active | 26-Apr-2018 | ||
| US-12409022-B2 | Systems and methods for protecting the cerebral vasculature | Active | 26-Apr-2018 | A61F2/013 |
Claret Medical Signals
Claret Medical Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Easton Capital Investment Group | Venture Capital | Minority | ||
| Gore Range Capital | Venture Capital | Minority | ||
| HealthCor Partners Management | Growth/Expansion | Minority | ||
| Incept | Venture Capital | Minority | ||
| Lightstone Ventures | Venture Capital | Minority |
Claret Medical FAQs
-
When was Claret Medical founded?
Claret Medical was founded in 2009.
-
Where is Claret Medical headquartered?
Claret Medical is headquartered in Santa Rosa, CA.
-
What is the size of Claret Medical?
Claret Medical has 120 total employees.
-
What industry is Claret Medical in?
Claret Medical’s primary industry is Surgical Devices.
-
Is Claret Medical a private or public company?
Claret Medical is a Private company.
-
What is the current valuation of Claret Medical?
The current valuation of Claret Medical is .
-
What is Claret Medical’s current revenue?
The current revenue for Claret Medical is .
-
How much funding has Claret Medical raised over time?
Claret Medical has raised $67M.
-
Who are Claret Medical’s investors?
Easton Capital Investment Group, Gore Range Capital, HealthCor Partners Management, Incept, and Lightstone Ventures are 5 of 7 investors who have invested in Claret Medical.
-
Who are Claret Medical’s competitors?
Open Stent Solution, Emboline, Revamp Medical, Emblok, and Artio are some of the 16 competitors of Claret Medical.
-
When was Claret Medical acquired?
Claret Medical was acquired on 02-Aug-2018.
-
Who acquired Claret Medical?
Claret Medical was acquired by Boston Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process